Primary mouse keratinocytes provide an ideal model for the study of multistep carcinogenesis. A unique feature of this system is that a direct connection can be established between in vitro and in vivo studies, by grafting of cultured keratinocytes back onto the animal. Our approach will involve introduction of activated growth-regulatory genes (oncogenes) into primary keratinocytes with evaluation of their possible effects on cells (a) in culture (in response to calcium, TPA defined media) and (b) in vivo, by grafting (ability to form well stratified epidermis, Benign or displastic papillomas, frankly invasive carcinomas). Oncogenes will be introduced into cells by means of a retroviral vector (MD) that we have specifically developed for high expression of foreign genes into primary keratinocytes. Genes that will be introduced into cells include: 1) ras oncogene. Use of a replication-defective MD-ras virus will provide a significant contribution to experiments already underway, concerning the role of ras activation as well as surrounding normal cells in benign versus malignant transformation of primary keratinocytes. 2) Nuclear oncogenes. Preliminary studies with two viruses carrying the Ela and p53 oncogenes will be directly continued. Construction of viruses carrying other nuclear oncogenes (myc and myb) will be undertaken. 3) Growth-factor related genes. Viruses with genes for EGF and EGF-receptor and the neu oncogene will be made and used to test the possible role of these genes during neoplastic evolution of epidermal cells. 4) Oncogenes in various combinations. Oncogene-carrying retroviruses will be constructed that carry different selectable markers. These viruses will be used as an alternative approach to helper virus in testing cooperative effects of various oncogenes in keratinocyte transformation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR039190-02
Application #
3159166
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1988-07-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Goruppi, Sandro; Jo, Seung-Hee; Laszlo, Csaba et al. (2018) Autophagy Controls CSL/RBPJ? Stability through a p62/SQSTM1-Dependent Mechanism. Cell Rep 24:3108-3114.e4
Al Labban, Dania; Jo, Seung-Hee; Ostano, Paola et al. (2018) Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B. J Clin Invest 128:2581-2599
Ă–zdemir, Berna C; Dotto, Gian-Paolo (2017) Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin? Trends Cancer 3:181-197
Goruppi, Sandro; Procopio, Maria-Giuseppina; Jo, Seunghee et al. (2017) The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI. Cell Rep 20:2468-2479
Kim, Dong Eun; Procopio, Maria-Giuseppina; Ghosh, Soumitra et al. (2017) Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation. J Exp Med 214:2349-2368
Dotto, G Paolo; Rustgi, Anil K (2016) Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. Cancer Cell 29:622-637
Lefort, Karine; Ostano, Paola; Mello-Grand, Maurizia et al. (2016) Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer. Oncotarget 7:48011-48026
Jo, Seung-Hee; Kim, Dong Eun; Clocchiatti, Andrea et al. (2016) PDCD4 is a CSL associated protein with a transcription repressive function in cancer associated fibroblast activation. Oncotarget 7:58717-58727
Menietti, Elena; Xu, Xiaoying; Ostano, Paola et al. (2016) Negative control of CSL gene transcription by stress/DNA damage response and p53. Cell Cycle 15:1767-78
Procopio, Maria-Giuseppina; Laszlo, Csaba; Al Labban, Dania et al. (2015) Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat Cell Biol 17:1193-204

Showing the most recent 10 out of 73 publications